Silo Pharma, Inc. (SILO)
CIK 1514183 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Silo Pharma, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 19, 2026 | 8-K | 0001213900-26-091783 |
| Aug 17, 2026 | 8-K | 0001213900-26-090748 |
| Aug 13, 2026 | 10-Q | 0001213900-26-089085 |
| Aug 13, 2026 | SCHEDULE 13G/A | 0001213900-26-088836 |
| Aug 6, 2026 | 424B3 | 0001213900-26-086219 |
| Aug 6, 2026 | EFFECT | 9999999995-26-002570 |
| Jul 31, 2026 | S-8 | 0001213900-26-083957 |
| Jul 24, 2026 | S-3 | 0001213900-26-081368 |
| Jul 14, 2026 | D | 0001213900-26-077974 |
| Jul 13, 2026 | 8-K | 0001213900-26-077296 |
| Jul 8, 2026 | SCHEDULE 13G | 0000929638-26-002570 |
| Jun 30, 2026 | DEF 14A | 0001213900-26-073367 |
| Jun 30, 2026 | ARS | 0001213900-26-073369 |
| Jun 30, 2026 | DEFA14A | 0001213900-26-073368 |
| Jun 18, 2026 | PRE 14A | 0001213900-26-070208 |
| Jun 18, 2026 | 8-K | 0001213900-26-070212 |
| Jun 3, 2026 | 8-K | 0001213900-26-064804 |
| Jun 1, 2026 | 8-K | 0001213900-26-063185 |
| May 14, 2026 | 10-Q | 0001213900-26-056079 |
| Apr 16, 2026 | 424B3 | 0001213900-26-044649 |
| Apr 15, 2026 | EFFECT | 9999999995-26-001189 |
| Apr 14, 2026 | 424B3 | 0001213900-26-043614 |
| Apr 14, 2026 | POS AM | 0001213900-26-043571 |
| Apr 13, 2026 | EFFECT | 9999999995-26-001163 |
| Apr 10, 2026 | POS AM | 0001213900-26-042614 |